Trials that use: ANCOVA
New to this method? Read the tutorial →
2,968 results
- AsthmaCareIndependent statistical analysis of Randomized Prospective Trial of a Mobile Health Application for Asthma Self-Management: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- At-Home Telehealth Yoga for Treating Chronic Pain in People With Alzheimer’s Disease and Their Caregiver’s: Complete Statistical AnalysisIndependent statistical analysis of At-Home Telehealth Yoga for Treating Chronic Pain in People With Alzheimer's Disease and Their Caregiver's: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Atacicept in Subjects With Optic Neuritis: Complete Statistical AnalysisIndependent statistical analysis of Atacicept in Subjects With Optic Neuritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00624468).
- ATLASIndependent statistical analysis of Efficacy, Safety, and Pharmacokinetic Profile of Etokimab (ANB020) in Adult Participants With Moderate-to-Severe Atopic Dermatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Atomoxetine and Huntington’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Atomoxetine and Huntington's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00368849).
- Atomoxetine to Treat Korean Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD): Complete Statistical AnalysisIndependent statistical analysis of Atomoxetine to Treat Korean Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Atomoxetine/Attention Deficit/ Hyperactive Disorder (ADHD)/Substance Use Disorder (SUD)in a Residential Treatment Facility: Complete Statistical AnalysisIndependent statistical analysis of Atomoxetine/Attention Deficit/ Hyperactive Disorder (ADHD)/Substance Use Disorder (SUD)in a Residential Treatment Facility: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Attachment Based Family Therapy for Suicidal Adolescents: Complete Statistical AnalysisIndependent statistical analysis of Attachment Based Family Therapy for Suicidal Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01537419).
- Attention Bias Modification Training for Young People: Complete Statistical AnalysisIndependent statistical analysis of Attention Bias Modification Training for Young People: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02270671).
- Audiobooks for Hearing Loss App as Auditory Training: Complete Statistical AnalysisIndependent statistical analysis of Audiobooks for Hearing Loss App as Auditory Training: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04231396).
- Audiovisual Aid Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of Audiovisual Aid Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02506673).
- Augmenting Effects of L-DOPS With Carbidopa and Entacapone: Complete Statistical AnalysisIndependent statistical analysis of Augmenting Effects of L-DOPS With Carbidopa and Entacapone: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00547911).
- Augmenting Growth Hormone to Ameliorate Nonalcoholic Fatty Liver Disease in Adolescents: Complete Statistical AnalysisIndependent statistical analysis of Augmenting Growth Hormone to Ameliorate Nonalcoholic Fatty Liver Disease in Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- AUR0613Independent statistical analysis of Blinded, Randomized Study Evaluating Aurstat Versus Control in the Treatment of Atopic Dermatitis Associated Pruritus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- AURA3Complete statistical analysis of AURA3, the randomized phase 3 trial of osimertinib versus platinum-based doublet chemotherapy in locally advanced or metastatic non-small cell lung cancer, including endpoints, statistical methods, efficacy results, safety,…
- AutonomyIndependent statistical analysis of A Study of JNJ-63733657 in Participants With Early Alzheimer's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04619420).
- AVALLIndependent statistical analysis of Assessment of an School-based Intervention in Eating Habits and Physical Activity in Schoolchildren: the AVall Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Avenir Müller Hip Stem Post Market Surveillance Study: Complete Statistical AnalysisIndependent statistical analysis of Avenir Müller Hip Stem Post Market Surveillance Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04079127).
- AVR_HEORIndependent statistical analysis of EaseVRx-8w+ for the Treatment of Chronic Lower Back Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05263037).
- AWARD-2Independent statistical analysis of A Study in Participants With Type 2 Diabetes Mellitus (AWARD-2): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01075282).
- AWARD-6Independent statistical analysis of the randomized phase 3 AWARD-6 trial comparing dulaglutide with liraglutide in type 2 diabetes, including the HbA1c non-inferiority analysis, secondary endpoints, statistical methods, safety, and interpretation.
- AWARD-CHN3Independent statistical analysis of A Study of Dulaglutide (LY2189265) in Chinese Participants With Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- AWARD-JPNIndependent statistical analysis of A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- AWARD-PEDSIndependent statistical analysis of A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Awareness Enhancement and Monitoring Device for Treatment of Trichotillomania: Complete Statistical AnalysisIndependent statistical analysis of Awareness Enhancement and Monitoring Device for Treatment of Trichotillomania: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01654523).
- AZMATICS: AZithroMycin/Asthma Trial In Community Settings: Complete Statistical AnalysisIndependent statistical analysis of AZMATICS: AZithroMycin/Asthma Trial In Community Settings: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00266851).
- Bacille Calmette-Guerin (BCG) Vaccine for Immune Protection Against Infections: Complete Statistical AnalysisIndependent statistical analysis of Bacille Calmette-Guerin (BCG) Vaccine for Immune Protection Against Infections: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04884308).
- Baclofen as a Perioperative Analgesic Adjuvant: Complete Statistical AnalysisIndependent statistical analysis of Baclofen as a Perioperative Analgesic Adjuvant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03720717).
- BACOPIndependent statistical analysis of Basel Discharge Communication Project: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01540266).
- BAILAIndependent statistical analysis of BAILA: Being Active, Increasing Latinos Healthy Aging: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01988233).
- BalanceIndependent statistical analysis of Impaired Regulation of Energy Balance in Elderly People (Balance Study): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00561145).
- Balance Function in Patients Post Corona Virus Disease 2019 (COVID-19): Complete Statistical AnalysisIndependent statistical analysis of Balance Function in Patients Post Corona Virus Disease 2019 (COVID-19): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04914364).
- Balance Recovery Training for Fall Prevention in Retirement Communities: Complete Statistical AnalysisIndependent statistical analysis of Balance Recovery Training for Fall Prevention in Retirement Communities: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02551666).
- Balance Training for People With Multiple Sclerosis Using Nintendo Wii Fit: Complete Statistical AnalysisIndependent statistical analysis of Balance Training for People With Multiple Sclerosis Using Nintendo Wii Fit: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- BALATONIndependent statistical analysis of A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion: primary endpoint results, effect estimate with confidence…
- Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension – CATALYST: Complete Statistical AnalysisIndependent statistical analysis of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- BARIIndependent statistical analysis of Biomarkers of Liver Pathology in Patients With Presumed Non-Alcoholic Steatohepatitis Following Bariatric Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- BBTIndependent statistical analysis of Beneficial Bacteria Treatment for Autism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02504554).
- BCAAIndependent statistical analysis of Mechanisms to Reduce Mental and Physical Fatigue Following Exercise Training in Older Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- BDJIndependent statistical analysis of Modulation Effects of Baduanjin Exercise on Subjective Cognitive Decline: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04009382).
- BE-SMARTIndependent statistical analysis of Brain Emotion Circuitry-Targeted Self-Monitoring and Regulation Therapy (BE-SMART): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03183388).
- BEACONIndependent statistical analysis of Comparison of Safety and Efficacy of the Combination Product QVA149A Against the Concurrent Administration of the Individual Components, QAB149 and NVA237, in Patients With Chronic Obstructive Pulmonary Disease…
- BED IN 31Independent statistical analysis of Reinforcing Effects of Cocaine During Phendimetrazine Maintenance: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02522325).
- Beet the Cold: The Effect of Inorganic Nitrate Supplementation in Individuals With Raynaud’s Phenomenon: Complete Statistical AnalysisIndependent statistical analysis of Beet the Cold: The Effect of Inorganic Nitrate Supplementation in Individuals With Raynaud's Phenomenon: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- BEGIN™Independent statistical analysis of Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- BEGIN™Independent statistical analysis of Comparison of NN1250 With Insulin Glargine Plus Insulin Aspart With/Without Metformin and With/Without Pioglitazone in Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- BEGIN™Independent statistical analysis of Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- BEGIN™Independent statistical analysis of Comparison of NN1250 With Insulin Glargine in Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01079234).
- Behavioral Activation (BA) for Medication-responsive Chronically Depressed Patients With Impaired Social Functioning: Complete Statistical AnalysisIndependent statistical analysis of Behavioral Activation (BA) for Medication-responsive Chronically Depressed Patients With Impaired Social Functioning: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Behavioral Insights to Encourage Judicious Prescribing of Opioids: Complete Statistical AnalysisIndependent statistical analysis of Behavioral Insights to Encourage Judicious Prescribing of Opioids: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02790476).